Institutions / Los Angeles Capital Management LLC / Activity
Activity — Los Angeles Capital Management LLC
2,059 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | Nucor Corp Common stock | $42.17M | +249K +2215.72% | 260,658 0.17% of portfolio | medium |
| Q1 2026 as of | Add | Allstate Corp Common stock | $42.03M | +203K +31.36% | 849,135 0.69% of portfolio | medium |
| Q1 2026 as of | Trim | Cincinnati Financial Corp Common stock | $-41.06M | -261K -75.14% | 86,342 0.05% of portfolio | medium |
| Q1 2026 as of | Add | Caris Life Sciences, Inc. Common stock | $40.93M | +2.3M +405139.29% | 2,289,602 0.16% of portfolio | medium |
| Q1 2026 as of | Add | Amgen Inc Common stock | $40.62M | +115K +160.00% | 187,621 0.26% of portfolio | medium |
| Q1 2026 as of | Trim | Hp Inc Common stock | $-39.92M | -2.1M -72.96% | 770,296 0.06% of portfolio | medium |
| Q1 2026 as of | Add | Micron Technology Inc Common stock | $39.85M | +118K +75.65% | 273,905 0.36% of portfolio | medium |
| Q1 2026 as of | Trim | BioMarin Pharmaceutical Inc Common stock | $-39.79M | -704K -63.36% | 407,379 0.09% of portfolio | medium |
| Q1 2026 as of | Add | Trane Technologies plc Common stock | $39.49M | +95K +20.20% | 563,799 0.93% of portfolio | medium |
| Q1 2026 as of | Add | Encompass Health Corp Common stock | $39.10M | +404K +314.67% | 532,646 0.20% of portfolio | medium |
| Q1 2026 as of | Trim | M&T Bank Corp Common stock | $-38.70M | -187K -54.89% | 153,839 0.13% of portfolio | medium |
| Q1 2026 as of | Trim | Veeva Systems Inc Common stock | $-38.03M | -216K -74.73% | 73,201 0.05% of portfolio | medium |
| Q1 2026 as of | Trim | Aecom Common stock | $-37.73M | -445K -89.28% | 53,432 0.02% of portfolio | medium |
| Q1 2026 as of | Trim | Comcast Corp. Common stock | $-37.38M | -1.3M -90.90% | 130,403 0.01% of portfolio | medium |
| Q1 2026 as of | Trim | Royal Gold Inc Common stock | $-37.32M | -147K -68.58% | 67,192 0.07% of portfolio | medium |
| Q1 2026 as of | Add | American Tower Corp Common stock | $37.08M | +215K +117.66% | 397,482 0.27% of portfolio | medium |
| Q1 2026 as of | Add | Expedia Group Inc Common stock | $36.93M | +160K +38.81% | 572,034 0.52% of portfolio | medium |
| Q1 2026 as of | Trim | Jabil Inc Common stock | $-36.85M | -139K -68.95% | 62,480 0.07% of portfolio | medium |
| Q1 2026 as of | Add | Keycorp /New Common stock | $36.84M | +1.8M +7524.18% | 1,861,977 0.15% of portfolio | medium |
| Q1 2026 as of | Add | Johnson Controls International plc Common stock | $36.13M | +276K +9324.50% | 278,871 0.14% of portfolio | medium |
| Q1 2026 as of | Add | Cadence Design Systems Inc Common stock | $35.92M | +129K +391.66% | 162,296 0.18% of portfolio | medium |
| Q1 2026 as of | Add | Cheniere Energy, Inc. Common stock | $35.22M | +124K +51.45% | 365,308 0.41% of portfolio | medium |
| Q1 2026 as of | Add | Ameriprise Financial Inc Common stock | $35.19M | +79K +373.85% | 100,375 0.18% of portfolio | medium |
| Q1 2026 as of | Add | Raymond James Financial Inc Common stock | $34.88M | +241K +248.03% | 338,002 0.19% of portfolio | medium |
| Q1 2026 as of | Trim | Apellis Pharmaceuticals, Inc. Common stock | $-34.83M | -866K -90.97% | 85,913 0.01% of portfolio | medium |
| Q1 2026 as of | Trim | Amphenol Corp /De Common stock | $-34.55M | -273K -12.30% | 1,948,877 0.97% of portfolio | medium |
| Q1 2026 as of | Add | Newmarket Corp Common stock | $33.32M | +52K +157548.48% | 52,024 0.13% of portfolio | medium |
| Q1 2026 as of | Trim | Duke Energy Corp Common stock | $-33.26M | -254K -89.82% | 28,773 0.01% of portfolio | medium |
| Q1 2026 as of | Add | Fidelity National Financial Inc Common stock | $32.86M | +708K +1805.20% | 747,637 0.14% of portfolio | medium |
| Q1 2026 as of | Trim | Resmed Inc Common stock | $-31.49M | -140K -98.40% | 2,280 <0.01% of portfolio | medium |
| Q1 2026 as of | Trim | Biogen Inc. Common stock | $-31.13M | -170K -82.76% | 35,358 0.03% of portfolio | medium |
| Q1 2026 as of | New | Millrose Properties, Inc. Common stock | $31.03M | +1.1M | 1,108,155 0.12% of portfolio | medium |
| Q1 2026 as of | Add | Antero Midstream Corp Common stock | $29.52M | +1.3M +2341.40% | 1,349,901 0.12% of portfolio | medium |
| Q1 2026 as of | Add | FactSet Research Systems Inc Common stock | $29.31M | +135K +75458.66% | 135,250 0.12% of portfolio | medium |
| Q1 2026 as of | Add | Public Service Enterprise Group Inc Common stock | $28.90M | +357K +2928.23% | 369,232 0.12% of portfolio | medium |
| Q1 2026 as of | Add | Cognizant Technology Solutions Corp Common stock | $28.53M | +465K +449.67% | 568,488 0.14% of portfolio | medium |
| Q1 2026 as of | Add | Mcdonald'S Corp Common stock | $28.51M | +92K +2830.48% | 94,977 0.12% of portfolio | medium |
| Q1 2026 as of | Add | Skyworks Solutions, Inc. Common stock | $28.51M | +532K +2868.39% | 550,904 0.12% of portfolio | medium |
| Q1 2026 as of | Trim | JPMorgan Chase & Co Common stock | $-28.38M | -96K -22.23% | 337,511 0.39% of portfolio | medium |
| Q1 2026 as of | Add | NOV Inc Common stock | $27.98M | +1.5M +94687.46% | 1,489,111 0.11% of portfolio | medium |
| Q1 2026 as of | Trim | Wells Fargo & COMPANY/MN Common stock | $-27.78M | -349K -20.24% | 1,375,304 0.43% of portfolio | medium |
| Q1 2026 as of | Trim | Regions Financial Corp Common stock | $-27.77M | -1.1M -56.89% | 805,685 0.08% of portfolio | medium |
| Q1 2026 as of | Add | BlackRock, Inc. Common stock | $27.46M | +29K +1605.06% | 30,333 0.11% of portfolio | medium |
| Q1 2026 as of | Add | Accenture plc Common stock | $27.45M | +138K +188.93% | 211,714 0.17% of portfolio | medium |
| Q1 2026 as of | Trim | TechnipFMC plc Common stock | $-27.21M | -394K -45.50% | 471,445 0.13% of portfolio | medium |
| Q1 2026 as of | Trim | Monster Beverage Corp Common stock | $-27.11M | -374K -31.98% | 795,804 0.23% of portfolio | medium |
| Q1 2026 as of | Trim | Boston Scientific Corp Common stock | $-26.96M | -430K -98.49% | 6,588 <0.01% of portfolio | medium |
| Q1 2026 as of | Trim | Grand Canyon Education, Inc. Common stock | $-26.60M | -156K -67.40% | 75,651 0.05% of portfolio | medium |
| Q1 2026 as of | Trim | Halozyme Therapeutics Inc Common stock | $-26.24M | -406K -37.05% | 689,915 0.18% of portfolio | medium |
| Q1 2026 as of | Add | US Bancorp \De Common stock | $26.17M | +503K +56.75% | 1,389,660 0.28% of portfolio | medium |